A young bowel cancer patient has shared five symptoms of the life-threatening disease she ignored before being diagnosed.
Guardant Health has secured Medicare coverage from Palmetto for its blood test to monitor for disease recurrence in patients with colorectal cancer.
Shares of Guardant Health (NASDAQ:GH) jumped 12% in early trading Tuesday on news that Medicare coverage for its Guardant Reveal blood test has been expanded to include monitoring for disease ...
Health Canada has granted market authorisation to Takeda Canada for FRUZAQLA capsules to treat adults with mCRC.